オンコリスバイオファーマ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4588/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/02/05 | 日証協 | 670,705株 | +12.16% | 11,500株 | -81.48% | 471,656株 | +16.36% | 12,200株 | -22.29% |
2016/01/29 | 日証協 | 598,000株 | -22.6% | 62,105株 | +37.4% | 405,356株 | -20.76% | 15,700株 | -35.66% |
2016/01/22 | 日証協 | 772,605株 | +0.23% | 45,200株 | -56.16% | 511,556株 | +1.03% | 24,400株 | -3.17% |
2016/01/15 | 日証協 | 770,805株 | +2.17% | 103,105株 | +71.26% | 506,356株 | +3.07% | 25,200株 | +240.54% |
2016/01/08 | 日証協 | 754,405株 | +6.24% | 60,205株 | +671.86% | 491,256株 | +12.76% | 7,400株 | -51.01% |
2015/12/30 | 日証協 | 710,100株 | +1.15% | 7,800株 | -73.91% | 435,652株 | -2.83% | 15,104株 | -12.67% |
2015/12/25 | 日証協 | 702,000株 | -9.27% | 29,900株 | -63.27% | 448,353株 | -10.2% | 17,295株 | +15.18% |
2015/12/18 | 日証協 | 773,700株 | -10.34% | 81,400株 | -31.65% | 499,256株 | -8.4% | 15,015株 | -25.3% |
2015/12/11 | 日証協 | 862,900株 | +14.9% | 119,095株 | -58.32% | 545,041株 | +9.86% | 20,100株 | -86.26% |
2015/12/04 | 日証協 | 751,000株 | +15.46% | 285,705株 | +140.66% | 496,141株 | +12.95% | 146,300株 | +358.62% |
2015/11/27 | 日証協 | 650,415株 | -1.3% | 118,715株 | +3108.51% | 439,256株 | +1.17% | 31,900株 | +2026.67% |
2015/11/20 | 日証協 | 659,015株 | +15.94% | 3,700株 | -26% | 434,156株 | +18.83% | 1,500株 | -40% |
2015/11/13 | 日証協 | 568,400株 | -13.04% | 5,000株 | -59.35% | 365,348株 | -15.03% | 2,500株 | -69.57% |
2015/11/06 | 日証協 | 653,615株 | +0.99% | 12,300株 | +272.73% | 429,963株 | +0.42% | 8,215株 | +39.24% |
2015/10/30 | 日証協 | 647,215株 | -1.1% | 3,300株 | -73.17% | 428,163株 | -2.53% | 5,900株 | +55.26% |
2015/10/23 | 日証協 | 654,415株 | -12.8% | 12,300株 | +925% | 439,263株 | -10.33% | 3,800株 | +153.33% |
2015/10/16 | 日証協 | 750,515株 | -0.05% | 1,200株 | -93.18% | 489,863株 | -0.55% | 1,500株 | -70% |
2015/10/09 | 日証協 | 750,915株 | +0.21% | 17,600株 | +38.58% | 492,563株 | +0.76% | 5,000株 | -67.33% |
2015/10/02 | 日証協 | 749,315株 | +1.05% | 12,700株 | +388.46% | 488,867株 | +1.47% | 15,303株 | +466.78% |
※株式分割は考慮していませんのでご注意ください。
Page Top